Skip to main content
Premium Trial:

Request an Annual Quote

Microba, University of Queensland Partner to Study Gut Microbiome in Parkinson's Disease

NEW YORK — Australian microbial genetics firm Microba said on Thursday that it has partnered with the University of Queensland to study the gut microbiome to identify novel biomarkers and treatments for Parkinson's disease.

According to Microba, research has linked changes in the gut microbiome with the onset of Parkinson's disease. Under the terms of the collaboration, the University of Queensland and Microba will use the company's metagenomic sequencing and analysis technologies to examine the link between the gut microbiome and Parkinson's disease in animal models and in patients.

The alliance's first human trial, which is being funded by the Queensland government and slated to begin later this year, aims to determine if an investigational treatment can restore beneficial gut microbiome species and improve symptoms such as constipation in Parkinson’s disease patients, Microba said.

Additional terms of the deal were not disclosed.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.